{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T09:43:55Z","timestamp":1773740635766,"version":"3.50.1"},"reference-count":31,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"accepted":{"date-parts":[[2023,6,23]]},"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:title>Importance<\/jats:title>\n               <jats:p>Prophylactic cyclo-oxygenase inhibitors (COX-Is) such as indomethacin, ibuprofen and acetaminophen may prevent morbidity and mortality in extremely preterm infants (born \u226428 weeks\u2019 gestation). However, there is controversy around which COX-I, if any, is the most effective and safest, which has resulted in considerable variability in clinical practice.<\/jats:p>\n               <jats:p>\n                  <jats:named-content content-type=\"indent\">\u2003<\/jats:named-content>Our objective was to develop rigorous and transparent clinical practice guideline recommendations for the prophylactic use of COX-I drugs for the prevention of mortality and morbidity in extremely preterm infants.<\/jats:p>\n               <jats:p>\n                  <jats:named-content content-type=\"indent\">\u2003<\/jats:named-content>The Grading of Recommendations Assessment, Development and Evaluation evidence-to-decision framework for multiple comparisons was used to develop the guideline recommendations. A 12-member panel, including 5 experienced neonatal care providers, 2 methods experts, 1 pharmacist, 2 parents of former extremely preterm infants and 2 adults born extremely preterm, was convened. A rating of the most important clinical outcomes was established a priori. Evidence from a Cochrane network meta-analysis and a cross-sectional mixed-methods study exploring family values and preferences were used as the primary sources of evidence.<\/jats:p>\n               <jats:p>\n                  <jats:named-content content-type=\"indent\">\u2003<\/jats:named-content>The panel recommended that prophylaxis with intravenous indomethacin may be considered in extremely preterm infants (conditional recommendation, moderate certainty in estimate of effects). Shared decision making with parents was encouraged to evaluate their values and preferences prior to therapy. The panel recommended against routine use of ibuprofen prophylaxis in this gestational age group (conditional recommendation, low certainty in the estimate of effects). The panel strongly recommended against use of prophylactic acetaminophen (strong recommendation, very low certainty in estimate of effects) until further research evidence is available.<\/jats:p>","DOI":"10.1136\/archdischild-2023-325445","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T13:30:18Z","timestamp":1688736618000},"page":"232-238","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in extremely preterm infants: a clinical practice guideline incorporating family values and preferences"],"prefix":"10.1136","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7477-7264","authenticated-orcid":false,"given":"Souvik","family":"Mitra","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada"},{"name":"Division of Neonatal Perinatal Medicine, IWK Health, Halifax, Nova Scotia, Canada"},{"name":"Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"Whitehead","sequence":"additional","affiliation":[{"name":"Division of Neonatal Perinatal Medicine, IWK Health, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Smith","sequence":"additional","affiliation":[{"name":"School of Access, Education and Language, Nova Scotia Community College, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Breagh","family":"Maclean","sequence":"additional","affiliation":[{"name":"Department of Service Nova Scotia, Government of Nova Scotia, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebekah","family":"Nixon","sequence":"additional","affiliation":[{"name":"Department of Neonatal Medicine, University Hospital Southampton NHS Foundation Trust, Southampton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Veysey","sequence":"additional","affiliation":[{"name":"Division of Neonatal Perinatal Medicine, IWK Health, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marsha","family":"Campbell-Yeo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada"},{"name":"Division of Neonatal Perinatal Medicine, IWK Health, Halifax, Nova Scotia, Canada"},{"name":"School of Nursing, Faculty of Health, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Kuhle","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada"},{"name":"Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada"},{"name":"Institute for Medical Biostatistics, Epidemiology and Informatics (IMBEI), Johannes Gutenberg University of Mainz, Mainz, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0707-876X","authenticated-orcid":false,"given":"Chris","family":"Gale","sequence":"additional","affiliation":[{"name":"School of Public Health, Imperial College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Soll","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Vermont, Burlington, New Jersey, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon","family":"Dorling","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada"},{"name":"Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada"},{"name":"Department of Neonatal Medicine, University Hospital Southampton NHS Foundation Trust, Southampton, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley C","family":"Johnston","sequence":"additional","affiliation":[{"name":"Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada"},{"name":"Department of Nutrition, College of Agriculture and Life Sciences, Texas A&M University, College Station, Texas, USA"},{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Texas A&M University, College Station, Texas, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,7,7]]},"reference":[{"key":"2025090221583617000_109.3.232.1","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2016.4396","article-title":"Variation in performance of neonatal intensive care units in the United States","volume":"171","author":"Horbar","year":"2017","journal-title":"JAMA Pediatr"},{"key":"2025090221583617000_109.3.232.2","doi-asserted-by":"crossref","unstructured":"Benitz WE . Committee on fetus and newborn, American academy of pediatrics. patent ductus arteriosus in preterm infants. Pediatrics 2016;37. doi:10.1542\/peds.2015-3730","DOI":"10.1542\/peds.2015-3730"},{"key":"2025090221583617000_109.3.232.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3468(89)80284-2"},{"key":"2025090221583617000_109.3.232.4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/jp.2016.196","article-title":"Effect of prophylactic indomethacin administration and early feeding on spontaneous intestinal perforation in extremely low-birth-weight infants","volume":"37","author":"Stavel","year":"2017","journal-title":"J Perinatol"},{"key":"2025090221583617000_109.3.232.5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jpeds.2017.05.005","article-title":"Bronze baby syndrome","volume":"188","author":"Le","year":"2017","journal-title":"J Pediatr"},{"key":"2025090221583617000_109.3.232.6","doi-asserted-by":"crossref","unstructured":"Travers CP , Gentle S , Freeman AE , et al . A quality improvement bundle to improve outcomes in extremely preterm infants in the first week. Pediatrics 2022;149. doi:10.1542\/peds.2020-037341","DOI":"10.1542\/peds.2020-037341"},{"key":"2025090221583617000_109.3.232.7","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-050652","article-title":"Reduction of severe Intraventricular hemorrhage in preterm infants: a quality improvement project","volume":"149","author":"Kramer","year":"2022","journal-title":"Pediatrics"},{"key":"2025090221583617000_109.3.232.8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjoq-2022-001904","article-title":"Perinatal excellence to reduce injury in preterm birth (Periprem) through quality improvement","volume":"11","author":"Glover Williams","year":"2022","journal-title":"BMJ Open Qual"},{"key":"2025090221583617000_109.3.232.9","unstructured":"Moberg J , Alonso-Coello P , Oxman AD . GRADE evidence to decision (Etd) frameworks guidance. version 1.1. The GRADE Working Group; 2015. Available: https:\/\/ietd.epistemonikos.org\/#\/help\/guidance"},{"key":"2025090221583617000_109.3.232.10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jclinepi.2020.10.016","article-title":"Using GRADE evidence to decision frameworks to choose from multiple interventions","volume":"130","author":"Piggott","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"2025090221583617000_109.3.232.11","doi-asserted-by":"publisher","DOI":"10.7326\/M18-3279"},{"key":"2025090221583617000_109.3.232.12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.2273","article-title":"Evaluation of health-related values and preferences of adults who were Preterm infants and parents of preterm infants concerning use of prophylactic cyclooxygenase inhibitor drugs","volume":"6","author":"Mitra","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2025090221583617000_109.3.232.13","article-title":"Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis","volume":"4","author":"Mitra","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090221583617000_109.3.232.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.09.012"},{"key":"2025090221583617000_109.3.232.15","article-title":"Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants","volume":"2010","author":"Fowlie","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090221583617000_109.3.232.16","article-title":"Ibuprofen for the prevention of patent ductus arteriosus in preterm and\/or low birth weight infants","volume":"6","author":"Ohlsson","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090221583617000_109.3.232.17","article-title":"Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants","volume":"1","author":"Ohlsson","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090221583617000_109.3.232.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2019.04.018"},{"key":"2025090221583617000_109.3.232.19","doi-asserted-by":"publisher","DOI":"10.1002\/nur.20147"},{"key":"2025090221583617000_109.3.232.20","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-0183"},{"key":"2025090221583617000_109.3.232.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2018.10.004"},{"key":"2025090221583617000_109.3.232.22","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/pxz056"},{"key":"2025090221583617000_109.3.232.23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/pch\/pxab085","article-title":"Management of the patent ductus arteriosus in preterm infants","volume":"27","author":"Mitra","year":"2022","journal-title":"Paediatr Child Health"},{"key":"2025090221583617000_109.3.232.24","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-1209","article-title":"Patent ductus arteriosus of the preterm infant","volume":"146","author":"Hamrick","year":"2020","journal-title":"Pediatrics"},{"key":"2025090221583617000_109.3.232.25","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m3900","article-title":"GRADE approach to drawing conclusions from a network meta-analysis using a partially contextualised framework","volume":"371","author":"Brignardello-Petersen","year":"2020","journal-title":"BMJ"},{"key":"2025090221583617000_109.3.232.26","unstructured":"Mcmaster University > CE&Amp;Amp;B grade > guideline development checklist. Available: https:\/\/cebgrade.mcmaster.ca\/guidecheck.html [Accessed 04 Dec 2019]."},{"key":"2025090221583617000_109.3.232.27","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i1152","article-title":"The AGREE reporting checklist: a tool to improve reporting of clinical practice guidelines","volume":"352","author":"Brouwers","year":"2016","journal-title":"BMJ"},{"key":"2025090221583617000_109.3.232.28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jpeds.2021.02.073","article-title":"Gestational age-dependent variations in effects of prophylactic indomethacin on brain injury and intestinal injury","volume":"235","author":"Qureshi","year":"2021","journal-title":"J Pediatr"},{"key":"2025090221583617000_109.3.232.29","doi-asserted-by":"crossref","DOI":"10.1038\/srep02539","article-title":"A predictive model for SIVH risk in Preterm infants and targeted indomethacin therapy for prevention","volume":"3","author":"Singh","year":"2013","journal-title":"Sci Rep"},{"key":"2025090221583617000_109.3.232.30","article-title":"Indomethacin for symptomatic patent ductus arteriosus in preterm infants","volume":"1","author":"Evans","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090221583617000_109.3.232.31","article-title":"Late (\u2265 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants","volume":"11","author":"Doyle","year":"2021","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2023-325445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T04:58:43Z","timestamp":1756875523000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/archdischild-2023-325445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,4,18]]},"published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1136\/archdischild-2023-325445"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2023-325445","relation":{},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"value":"1359-2998","type":"print"},{"value":"1468-2052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,7]]}}}